The sterile injectables CDMO market is poised for growth due to the rising demand for biologics, biosimilars, and advanced injectable formats. Opportunities include expansion in large molecule and ...
In this Pharma Matters Q&A, Anshul Gupte of PCI Pharma Services discusses investments and opportunities in sterile ...
-Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation Amneal will install dedicated manufacturing ...
Five years after partnering up with Berkshire Sterile Manufacturing, Sharp Services is buying out the fill-finish CDMO for an undisclosed sum. Sharp, a 71-year-old subsidiary of Ireland-based UDG ...
Undergraduate students recently visited the SMU to aseptically manufacture lipid nanoparticles. Credit: Nathaniel Milton. WEST LAFAYETTE, Ind. — A mobile laboratory that Eli Lilly and Company used to ...
The two companies intend to leverage their complementary expertise and technology to bring a novel long acting injectable and drug product manufacturing platform to market. SACRAMENTO, Calif., Aug. 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results